Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 11 publications
Phase 2 trial of a multivalent WT1 peptide vaccine (galinpepimut-S) in acute myeloid leukemia.
Journal: Blood advances
Published: November 13, 2017
Patterns of hydroxyurea use and clinical outcomes among patients with polycythemia vera in real-world clinical practice: a chart review.
Journal: Experimental hematology & oncology
Published: September 24, 2015
A pooled analysis of overall survival in COMFORT-I and COMFORT-II, 2 randomized phase III trials of ruxolitinib for the treatment of myelofibrosis.
Journal: Haematologica
Published: October 28, 2014
Myelofibrosis-associated complications: pathogenesis, clinical manifestations, and effects on outcomes.
Journal: International journal of general medicine
Published: February 07, 2014
Management of cytopenias in patients with myelofibrosis treated with ruxolitinib and effect of dose modifications on efficacy outcomes.
Journal: OncoTargets and therapy
Published: December 26, 2013
Progressive burden of myelofibrosis in untreated patients: assessment of patient-reported outcomes in patients randomized to placebo in the COMFORT-I study.
Journal: Leukemia research
Published: January 29, 2013
Ruxolitinib, an oral JAK1 and JAK2 inhibitor, in myelofibrosis.
Journal: Expert opinion on pharmacotherapy
Published: October 12, 2012
A randomized trial of a single-dose rasburicase versus five-daily doses in patients at risk for tumor lysis syndrome.
Journal: Annals of oncology : official journal of the European Society for Medical Oncology
Published: October 22, 2011
Showing 1-11 of 11
Last Updated: 09/26/2026